Lecture Notes

**Lecture Coverage:**
- Drug Interactions
- Pharmaceutical Interactions
- Pharmacodynamic Interactions
- Pharmacokinetic Interactions
- Food-Drug Interactions

---
#### **Drug Interactions**
- The process where the Object Drug action is affected by the Precipitant Drug
	- Only Important if Object Drug has steep CRC / narrow Therapeutic Window

**Types of Drug Interactions**
- Pharmaceutical: Chemical Reaction between Drugs / Infusion Fluid
- Pharmacodynamic: Interaction of Drugs with Conflicting Targets / Actions
- Pharmacokinetic: Interaction of Drugs affecting ADME


#### **Pharmaceutical Interactions**
- Reaction of Object Drug with:
	- Infusion Fluid Substances (e.g. Glucose)
	- Other Drugs
- Effects:
	- Precipitation → Toxicity / ↓ Drug Activity
	- Detoxification if Overdose

**Examples of Pharmaceutical Interactions**

|         Object Drug         | Precipitant Drug |          Effect           |
| :-------------------------: | :--------------: | :-----------------------: |
|    Diazepam / Phenytoin     |  Infusion Fluid  |     <br>Precipitation     |
| Thiopentone / Suxamethonium |        <         |             ^             |
|           Digoxin           |    Antibodies    | Digibind (Detoxification) |


#### **Pharmacodynamic Interactions**
- Mostly happen when drugs have 
	- Competitive Antagonism at same site
	- Functional Antagonism / Synergism
- Either Lowers / Further Enhance Drug Efficiency

**Examples of Competitive Antagonism between Drugs**

|        Competing Drugs (Disease)        |                                                 <                                                  |             Effect              |
| :-------------------------------------: | :------------------------------------------------------------------------------------------------: | :-----------------------------: |
| β1 Antagonists (Coronary Heart Disease) |                                    β2 Agonists (COPD / Asthma)                                     | ↓ Bronchodilation Effectiveness |
|             Opioids (Pain)              | <abbr Title="Opioid Receptor Antagonist">Naloxone</abbr> (Opioid <abbr Title="Overdose">OD</abbr>) |          ↓ Painkilling          |

**Examples of Functional Synergism between Drugs**

|                    Synergizing Drugs (Function)                     |                                                             <                                                             |                                         Effect                                          |
| :-----------------------------------------------------------------: | :-----------------------------------------------------------------------------------------------------------------------: | :-------------------------------------------------------------------------------------: |
|                       Aspirin (GI Ulceration)                       |                                                 Warfarin (Anticoagulant)                                                  |                                  GI Excessive Bleeding                                  |
| <abbr Title="Loop Diuretics">Furosemide</abbr> (K<sup>+</sup> Loss) | <abbr Title="Antiarrhythmics">Digoxin</abbr> (Competitive Na<sup>+</sup>/K<sup>+</sup> ATPase Inhibitor of K<sup>+</sup>) |                                    ↑ Digoxin Effect                                     |
|                       Ethanol (GABAR Agonist)                       |                                             Promethazine (Sedative Hypnotics)                                             | Additive Sedation / <abbr Title="Poor Muscular Coordination">Ataxia</abbr> / Depression |


#### **Pharmacokinetic Interactions**
- Happens during ADME

**Pharmacokinetic Interactions during Absorption**
- Precipitant Drugs modulating Absorption of Object Drugs
	- Can be facilitative / disruptive

|                             Drug                              |           Mechanism            | Effect on Object Drug Absorption                         |
| :-----------------------------------------------------------: | :----------------------------: | -------------------------------------------------------- |
|                        Metoclopramide                         |         ↑ GI Motility          | ↑                                                        |
|                     Antacids & Sucralfate                     |          ↓ Absorption          | ↓ Tetracycline / Quinolones                              |
| <abbr Title="Proton Pump Inhibitors">PPIs</abbr> (Omaprazole) | ↓ Stomach H<sup>+</sup> → ↑ pH | <abbr Title="∵ ↓ Ionization">↓ Weakly Basic Drugs</abbr> |


**Pharmacokinetic Interactions during Distribution**
- Competition for PPB → ↑ Free Competing Drugs in Plasma → OD
	- Increases CL → ↑ in Free Drug may be a transient problem
	- Clinically Critical if Drug has low V & Patient has low CL of Drug
		- Low V = Drug stays longer in Plasma
		- Low CL: Possibly due to Precipitant Drug preventing Metabolism / Excretion
	- [[Lecture 2.2 - (Pharmacokinetics) Distribution#**Factors Affecting Distribution**|Examples of Highly PPB Drugs]]


**Pharmacokinetic Interactions during Metabolism**
- Phase I [[Lecture 2.3 - (Pharmacokinetics) Metabolism#**Factors Affecting Drug Biotransformation**|Enzyme Induction]] → Faster Drug Metabolism → Lowered Drug Effect
- Inhibition of CYP450 → Slow Drug Metabolism → OD

| Inhibitor  | Effect on H2R Antagonism | Effect on CYP Inhibition |
| :--------: | :----------------------: | :----------------------: |
| Cimetidine |           idk            |            <             |
| Ranitidine |           idk            |           Weak           |
| Famotidine |          Strong          |         Minimal          |

**Pharmacokinetic Interactions during Excretion**
- Competition for same transport mechanism in proximal tubules → Slow Excretion → OD

| Object Drug  | Precipitant Drug |     Effect      |
| :----------: | :--------------: | :-------------: |
|   Digoxin    |    Quinidine     |   Digoxin OD    |
| Methotrexate |    Salicylate    | Methotrexate OD |
